Exane BNP Paribas analyst Jeff Stent upgraded Nestle (NSRGY) to Outperform from Underperform with a price target of CHF 89, up from CHF 80. The company’s earnings “bleed” is finished and there is material upside potential to fiscal 2025 sales growth estimates, the analyst tells investors in a research note.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NSRGY:
- Nestle downgraded to Underperform from Hold at Jefferies
- Nestle initiated with a Buy at Goldman Sachs
- Freight Technologies selected by Nestle Mexico to provide logistics services
- Nestle upgraded to Equal Weight from Underweight at Morgan Stanley
- Nestle chairman says company will have to take action on prices, Reuters says
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
